AI and computational design at Antibody Engineering 2026

Dec 13–16, 2026 San Diego, CA ~900 attendees Website

28 organizations at Antibody Engineering 2026 present work in AI & computational design: 17 suppliers and service providers, 6 drug developers and 5 academic, government and non-profit bodies. Between them they bring 29 presentations to the program. Most represented: Amgen (3 on the program), Twist Bioscience (2 on the program), Nona Biosciences (2 on the program). As of Nov 10, 2026.

All 168 organizations at Antibody Engineering 2026 →

Format
Top represented
Showing 1–15 of 28 organizations
OrganizationAntibody Engineering 2026 Attendance
Amgen
Thousand Oaks, CA
Large pharma
Global biopharmaceutical company developing and manufacturing biologic medicines, including bispecific T-cell engagers.
Chair
Sun Dec 13
1:00pm–1:15pm
Co-Chairs' Remarks: From Discovery to IND: What Matters Most and How to Get it Right
Workshop 1: From Discovery to IND: What Matters Most and How to Get it Right · with Xencor
Talk
Sun Dec 13
1:15pm–1:45pm
Developability-Guided Generative Biology for Therapeutic Protein Engineering
Designing new therapeutic proteins by computer while checking from the start that they can be made and purified.
AI & computational design
Talk
Sun Dec 13
4:15pm–5:00pm
Moderated Panel Discussion with Session Speakers
Workshop 1: From Discovery to IND: What Matters Most and How to Get it Right · with Xencor
Talk
Mon Dec 14
5:45pm–6:15pm
Induced Proximity and Next-Generation Antibody Therapeutics
Track 2: Engineering Solutions for Accessing Difficult Targets
Bispecifics & multispecifics
Twist Bioscience
South San Francisco, CA
Reagents & consumablesEvent partner
Synthetic DNA company whose biopharma unit provides antibody libraries and antibody discovery and optimization services.
Booth
Exhibiting at Booth 200
Mon, Dec 144:00pm–4:45pmTue, Dec 159:45am–4:45pm
Talk
Mon Dec 14
12:15pm–1:15pm
Scaling Wet-Lab Validation for AI-based Biologic Discovery
Why lab testing has become the bottleneck for AI antibody design, and how a shared model platform from Eli Lilly connects to it.
with Eli Lilly
AI & computational designAntibody discovery
Talk
Tue Dec 15
1:40pm–2:00pm
Screening in the Format You’ll Develop In: Cell-Free Expression of Full-Length IgG
Making full-length antibodies without cells at screening scale, and how their binding compares with the same antibodies made in mammalian cells.
Antibody discovery
Talk
Wed Dec 16
7:30am–8:00am
Engineering for Better Bispecifics: Introducing the B-Body® Platform
A two-target antibody design meant to assemble reliably, avoiding low yields and hard purification when production scales up.
Bispecifics & multispecificsDevelopability & CMC
Discovery platformsBronze sponsor
Fully human antibody discovery built on its Harbour Mice transgenic platforms for conventional and heavy-chain-only antibodies, offered as integrated discovery services.
Booth
Exhibiting at Booth 203
Mon, Dec 144:00pm–4:45pmTue, Dec 159:45am–4:45pm
Talk
Mon Dec 14
1:45pm–2:15pm
A Fully Human, AI-native Discovery and Development Platform for Next-generation Modality Solutions
How fully human antibody mice combined with AI design feed immune cell engagers, brain-crossing antibodies, drug conjugates and other complex formats.
Antibody discoveryAI & computational design
Talk
Tue Dec 15
11:30am–12:00pm
VHH to Mice – With a Focus on In vivo Discovery/Screening Approaches for Therapeutic Discovery Applications
Why single-domain human antibodies from engineered mice suit CAR-T cells and T-cell engagers, and how testing for target-cell killing picks better candidates.
Bispecifics & multispecifics
Academic
Public research university in Austin, Texas.
Talk
Mon Dec 14
5:15pm–5:45pm
Computational Approaches for Antibody and TCR Modeling Design and Discovery
Track 1: Emerging In Vitro Approaches to Antibody Discovery
AI & computational design
Talk
Tue Dec 15
10:30am–11:00am
Utilizing Repertoire Mining to Complement In Vivo Antibody Discovery for Antibody Therapeutics
Track 1: Advanced In Vivo Approaches to Antibody Discovery
A-Alpha Bio
Seattle, WA
Discovery platformsBronze sponsor
Measures protein-protein binding at scale with its AlphaSeq platform and uses the data to train models for antibody optimization with partners.
Booth
Exhibiting at Booth 405
Mon, Dec 144:00pm–4:45pmTue, Dec 159:45am–4:45pm
Talk
Tue Dec 15
12:35pm–1:05pm
Predictive Multi-Objective Antibody Optimization Powered by Millions of Quantitative Affinity Measurements
A model trained on millions of binding-strength measurements that predicts how far an antibody can be mutated and still bind.
AI & computational designProtein engineering
Asimov
Boston, MA
CRO & CDMOBronze sponsor
Offers CHO cell line development services built on its CHO Edge expression system and genetic design software for biologics manufacturing.
Booth
Exhibiting at Booth 101
Mon, Dec 144:00pm–4:45pmTue, Dec 159:45am–4:45pm
Talk
Mon Dec 14
1:45pm–2:15pm
An AI-Driven Approach to CHO Biologics Production
How a platform combining AI and synthetic biology builds high-yield Chinese hamster ovary cell lines for antibodies, including bispecific and multispecific ones.
Developability & CMCAI & computational design
CRO & CDMOSilver sponsor
Provides recombinant antibody expression and production services, plus antibody discovery, for drug developers.
Booth
Exhibiting at Booth 212
Mon, Dec 144:00pm–4:45pmTue, Dec 159:45am–4:45pm
Talk
Tue Dec 15
12:05pm–12:35pm
Wet-lab data acquisition for rapid iteration of AI-powered macromolecular drugs
Standardized lab data delivered in days, so the AI models designing millions of antibody candidates can be retrained more quickly.
AI & computational design
Cradle
Amsterdam, Netherlands
Software & AIAssociate sponsor
AI software for protein engineering that suggests improved antibody and protein sequences from lab data.
Booth
Exhibiting (no floor booth listed)
Mon, Dec 144:00pm–4:45pmTue, Dec 159:45am–4:45pm
Talk
Tue Dec 15
12:35pm–1:05pm
Generative AI for End-to-End Biologics Engineering: Scalable, Robust and Lab-Validated
How generative AI is applied across antibody and protein engineering, from first designs to optimizing several properties, with lab testing feeding the models.
AI & computational designProtein engineering
Software & AIBronze sponsor
Formerly ImmunoPrecise Antibodies; combines AI data tools such as LensAI and ReefIQ with wet-lab antibody discovery.
Booth
Exhibiting at Booth 312
Mon, Dec 144:00pm–4:45pmTue, Dec 159:45am–4:45pm
Talk
Mon Dec 14
1:15pm–1:45pm
From Fragmented Data to Reasoning Infrastructure: How ReefIQ and LensAI Turn Antibody Discovery Data Into Governed, Computable Biology
Linking scattered antibody sequence, structure and assay records so software can reason over them instead of rebuilding the links.
AI & computational design
BigHat Biosciences
San Mateo, CA
Biotech
Designs antibody therapeutics with machine learning and a high-throughput wet lab; runs its own pipeline and pharma partnerships.
Talk
Tue Dec 15
5:15pm–5:45pm
Machine Learning Guided Design of Avidity- and Logic-Gated T Cell Engagers
Using machine learning to tune binding strength so T-cell-recruiting antibodies act on diseased cells and spare healthy ones.
AI & computational design
Divergence Labs
New York, NY
Biotech
Drug developer combining computational models and lab work to discover medicines, with ophthalmology programs in its pipeline.
Talk
Mon Dec 14
3:00pm–3:30pm
One-Shot Antibody Design with AI: Are We There Yet?
An assessment of how much of computer-designed antibody discovery really works today, and what still does not.
AI & computational design
Eli Lilly
Indianapolis, IN
Large pharma
Global pharmaceutical company whose TuneLab platform offers biotech companies AI models trained on Lilly research data.
Talk
Mon Dec 14
12:15pm–1:15pm
Scaling Wet-Lab Validation for AI-based Biologic Discovery
Why lab testing has become the bottleneck for AI antibody design, and how a shared model platform from Eli Lilly connects to it.
with Twist Bioscience
AI & computational designAntibody discovery
EMD Serono
Rockland, MA
Large pharma
US and Canadian healthcare business of Merck KGaA, Darmstadt, developing medicines in oncology, neurology and fertility.
Talk
Sun Dec 13
1:45pm–2:15pm
A Combined Computational and Experimental Cascade for Variable Domain Assessment and Optimization Towards Developable Multispecific Antibodies
Splitting a multi-target antibody into its binding pieces and improving each one without losing target binding.
AI & computational design
EpiVax
Providence, RI
Software & AI
Offers in silico immunogenicity screening tools and matching human immune assays for antibody and protein therapeutics.
Panel
Sun Dec 13
4:15pm–4:45pm
Beyond Sequence Prediction: Integrating AI-Driven In Silico Analysis with Human Immune Assays for Antibody Engineering
Combining predictions of immune reactions against a drug with tests on human blood cells to design safer antibodies.
AI & computational design
Academic
Medical school of the Mount Sinai Health System in New York.
Talk
Wed Dec 16
8:45am–9:15am
From Nanobody Repertoires to Programmable Medicines: Proteomics, AF3-TurboAb, and Multivalent Design
Designing small single-domain antibodies using computer models of how they grip their targets, aimed at infections, toxins and cancer.
AI & computational design

Explore the full Antibody Engineering 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Diego. Leave your work email and we’ll be in touch.

Privacy

Download the full Antibody Engineering 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers in AI & computational design

Tell us what you sell and we’ll find the people at organizations working on AI & computational design most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse Antibody Engineering 2026 by

Exhibit hall

Not affiliated with or endorsed by Antibody Engineering & Therapeutics, its organizers or The Antibody Society. Submit a correction